LONDON, May 19, 2015 /PRNewswire/ -- This study provides a comprehensive analysis of the global market for nanoparticle size and characterization analysis instrumentation in the life sciences. Forecasts are provided by product, product category and by company from 2012 through 2019.Detailed instrument product and technical measurements analyses, characterization of biopharmaceutical and biological product, to overall industry trends, in order to qualify and quantify the market for analytical instrumentation used for nanoparticle analysis is covered in this report.
Use this report to:
- Identify the specific classes of nanoparticles instrumentation and the pharmaceutical and biotechnology products associated with them.
- Receive analysis of the market for nanoparticle size and characterization analysis instrumentation in the life sciences on a global basis.
- Receive a range of information from detailed instrument product analyses, technical measurements analyzed, to overall industry trends.
- Learn about the companies poised to introduce products in the industry during the forecast period and how these introductions will change the face of the competitive
- The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.
- Electron microscopy as a segment is expected to reach $2.4 billion in 2014. It is further projected to grow to nearly $2.9 billion in 2019, with a CAGR of 4.2% for the five-year period, 2014 to 2019.
- Optical microscopy as a segment is expected to reach $1.7 billion in 2014. It is further projected to grow to about $2.3 billion in 2019, with a CAGR of 5.9% for the five-year period, 2014 to 2019.
STUDY GOALS AND OBJECTIVES
This study provides a comprehensive analysis of the market for nanoparticle size and characterization analysis instrumentation in the life sciences on a global basis. Particular attention is given to drug development, formulation and quality control application in the production of life sciences products, drugs, biologicals and nanoparticle applications. Its aim is to provide a range of information, from detailed instrument product analyses, technical measurements analyzed, biopharmaceutical and biological product characterization, to overall industry trends, in order to qualify and quantify the market for analytical instrumentation used for nanoparticle analysis. The applicability of specific types of nanoparticle instrumentation for specific applications is discussed. Forecasts and trends are developed from a cross reference of data points, gleaned
from proprietary industry sources, company publications, industry benchmarking and other divergent data sources to arrive at a cogent and coordinated forecast.
REASONS FOR DOING THE STUDY
For companies with an effective strategy, market opportunity awaits. Importantly, the ability to develop an effective strategy begins with where opportunity exists and ends
with how to effectively execute to capture profit from opportunity. The nanoparticle analysis market presents an increasingly significant part of the overall pharmaceutical product analysis market worldwide. This study investigates the specific classes of nanoparticles instrumentation and the pharmaceutical/ biotechnology products associated with them. Existing instrument products and potential new instrument or new methods of analysis in the pipelines of the major instrumentation players in this market are reviewed.
Growing health concerns in developing countries are expected to continue to contribute substantially to market growth for biopharmaceuticals. This growth will stimulate growth in the instrumentation segment and is forecast for the period of 2014 to 2019. This report analyzes emerging markets by technology category. Continued growth is expected in emerging geographies, driven by the health awareness of the growing middle class in emerging countries such as India, China, Brazil and Russia. This report seeks to address the critically important topics of analyzing a changing market dynamic, emerging players and products, strategies for accessing emerging markets, specific instrument companies and global geographies in order to allocate resources and make effective decisions.
SCOPE OF REPORT
Current and projected product forecasts during the forecast period (2014 to 2019) are discussed. New product launches will be discussed. Revenue figures for 2013 are actual figures, except where actual results have not been reported, due to the timing of the release of this report. The report includes analysis of leading and emerging nanoparticle instrumentation categories. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.
Market figures are based on revenues at the manufacturers' level and are projected at 2013-dollar value. Inflation is not computed into the projection figures. Trends are
assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products and other factors affecting the market. Included in this report are forecasts by product, product category and by company from 2012 through 2019. The study is arranged to offer an overview of existing nanoparticle instrumentation technology, company, geography and mechanism of analysis with forecasts broken down and covered by geographic region or country. Patent information is reviewed for various technologies. The status of approvals by regulatory agencies, where appropriate, is reviewed. Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies. All market share data presented is on a global basis, unless specifically noted.
This report is an invaluable tool for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the nanoparticle analytical instrumentation and its impact on the biological drug market, its products, its industry participants and its
future. The importance of identifying overall market trends, product opportunities, emerging geographies, merger and acquisition (M&A) opportunities and insights that provide guidance for sales growth or defensive moves cannot be overstated for a variety of constituents, including:
- Established companies in the industry will benefit from the contents, including corporate strategy, sales and marketing, business development and R&D.
- Emerging players in the segment must understand specific opportunities for out-licensing, originating from the elements of differentiation of their product or
technology as compared to leading, competitive and emerging products. As well, market forecasts can support investment, provided a thorough and detailed
substantiation is provided for the market forecast, as is found in this study.
- Investment firms evaluating candidates for venture capital or hedged investments will gain insights as to the opportunity and risks that are being encountered in the
industry, in a product and company specific analysis.
- Equity analysts are provided detailed forecasts for the next five years, substantiated by quantitative analysis that can support further analysis to product and company
forecasts over the short and long run.
METHODOLOGY AND INFORMATION SOURCES
In-depth interviews were conducted with leading experts in the field who are executives in companies, industry analysts and leading individuals in the field. The nanoparticle instrument technology market comprises a variety of technologies analyzing the specific, unique properties of the ultra-small particles. For completeness,
the current and forecasted markets comprise the total market opportunity for each respective segment. Information to prepare this report was obtained from participating and emerging companies in the nanoparticle instrumentation area from the National Library of Medicine (NLM, NIH). Information was obtained from a variety of industry and technical journals in the various specialties of nanoparticle instrument applications. Other sources included the New York Times, Wall Street Journal, Washington Post, other
newspapers and company documents and other company Internet websites. Also used were journals such as the Journal of Nanoparticle Research, RNA, Journal of Industry
and Technology, and organizations such as Nanopatricle.org, Australian Government's National Institute for Measurement, the U.S. National Institute of Standards and technology (NIST), Royal Pharmaceutical Society of Great Britain, and the Society of Imaging Science and Technology.
Population estimates are based on those reported by the international database of the U.S. Census Bureau. Statistical data was obtained from the World Health Organization
(WHO), National Institutes of Health (NIH) and WHO Collaborating Centre for Drug Statistics Methodology (Norway). Current and historical revenue figures for individual products have been sourced from company disclosures that exist in the public domain or from government sources.
Download the full report: https://www.reportbuyer.com/product/2354693/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48